|
[1] ClasusN , TobiasH , StefanL , etal.Long-termfollow-upHBeAg-positivepatientstreatedwithinterferonalfaforchronichepatitisB[J].NEnglJMed, 1996, 334∶1422-1427
|
|
[2] ChingLL , RongNC , LeungN , etal.Aone-yeartrialoflamivudineforchronichepatitisB[J].NEnglJMed, 1998, 339∶61-68.
|
|
[3] PolS , MichelML , BrechotC .ImmunetherapyofhepatitisBviruschronicinfection[J].Hepatology, 2000, 31∶548-549.
|
|
[4] CouillinI , PolS , ManciniM , etal.SpecificvaccinetherapyinchronichepatitisB∶InductionofTcellproliferativeresponsesspecificforenvelopeantigens[J].JInfectDis, 1999, 180∶15-26.
|
|
[5] PolS , NalpasB , DrissF , etal.Efficacyandlimitationsofaspecificim munotherapyinchronichepatitisB[J].Hepatol, 2001, 34∶917-921.
|
|
[6] AkbarSMF , AbeM , MatsumotoT , etal.MechanismofactionofvaccinetherapyinmurinehepatitisBviruscarriers∶vaccine-inducedactivationofantigenpresentingdendriticcells[J].JHepatol, 1999, 30∶755-764.
|
|
[7] FrancoA , GuidottiG , HobbsMV , etal.PathogeneticeffectorfunctionofCD4+-postiveThelper1cellsinhepatitisBvirustransgenicmice[J].JImmunol, 1997, 159∶2001-2008.
|